773 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
AMGN Amgen Inc. $200.81 $129.98B N/A
Article Searches
Novartis Tops Q1 Earnings: Cosentyx, Entresto Boost Sales http://www.zacks.com/stock/news/257769/novartis-tops-q1-earnings-cosentyx-entresto-boost-sales?cid=CS-ZC-FT-257769 Apr 25, 2017 - Novartis AG (NVS) reported first-quarter 2017 core earnings of $1.13 per share, beating the Zacks Consensus Estimate of $1.10.
Biogen (BIIB) Q1 Earnings & Sales Top, Spinraza Sales Strong http://www.zacks.com/stock/news/257731/biogen-biib-q1-earnings-sales-top-spinraza-sales-strong?cid=CS-ZC-FT-257731 Apr 25, 2017 - Biogen Inc. (BIIB) reported better-than-expected results in the first-quarter of 2017. The company surpassed expectations both for earnings and sales.
Bleak Outlook for Big Drug Makers https://www.wsj.com/articles/bleak-outlook-for-big-drug-makers-1493051153?mod=rss_markets_main Apr 25, 2017 - Without price increases or deals to boost earnings, the pharmaceuticals sector faces a weak earnings season.
3 Stocks Could Double Their Dividends -- But Shouldn't https://www.fool.com/investing/2017/04/25/3-stocks-could-double-their-dividends-but-shouldnt.aspx?source=iedfolrf0000001 Apr 25, 2017 - A big dividend raise isn't always the right move for a business.
Why Earnings Season Could Be Great for Amgen (AMGN) http://www.zacks.com/stock/news/257630/why-earnings-season-could-be-great-for-amgen-amgn?cid=CS-ZC--257630 Apr 25, 2017 - Amgen (AMGN) is seeing encouraging earnings estimate revision activity as of late and carries a favorable rank, positioning the company for a likely beat this season.
Drug Stocks Q1 Earnings Releases on Apr 26: AMGN, GSK & More http://www.zacks.com/stock/news/257568/drug-stocks-q1-earnings-releases-on-apr-26-amgn-gsk-more?cid=CS-ZC-FT-257568 Apr 25, 2017 - Here we have four pharma companies that are set to report first-quarter results on Apr 26. Let's see how things are shaping up for this quarter.
Celgene (CELG) to Post Q1 Earnings: What's in the Cards? http://www.zacks.com/stock/news/257547/celgene-celg-to-post-q1-earnings-whats-in-the-cards?cid=CS-ZC-FT-257547 Apr 24, 2017 - Celgene Corporation (CELG) is scheduled to report first-quarter 2017 results on Apr 27, before the opening bell.
Is Pain Ahead for Healthcare ETFs After Weak JNJ Q1? http://www.zacks.com/stock/news/257491/is-pain-ahead-for-healthcare-etfs-after-weak-jnj-q1?cid=CS-ZC-FT-257491 Apr 24, 2017 - Results from Johnson and Johnson could be a warning sign for other drug makers, which are scheduled to report this week and the next.
What's in Store for Agenus (AGEN) this Earnings Season? http://www.zacks.com/stock/news/257483/whats-in-store-for-agenus-agen-this-earnings-season?cid=CS-ZC-FT-257483 Apr 24, 2017 - Agenus Inc. (AGEN) is expected to report first-quarter 2017 results later this month or early next month.
Better Buy: Amgen Inc. vs. Pfizer https://www.fool.com/investing/2017/04/24/better-buy-amgen-inc-vs-pfizer.aspx?source=iedfolrf0000001 Apr 24, 2017 - How do Amgen and Pfizer stocks stack up against each other?

Pages: 1...6162636465666768697071...78

<<<Page 66>